Y-mAbs Therapeutics, Inc. Bonus & Incentive Agreements
9 Contracts & Agreements
- Form of Performance Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2018 Equity Incentive Plan (Filed With SEC on February 29, 2024)
- Form of Stock Option Grant Notice and Stock Option Agreement for directors under the 2018 Equity Incentive Plan (Filed With SEC on November 7, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on November 7, 2022)
- Form of Retention Bonus Agreement of Y-mAbs Therapeutics, Inc (Filed With SEC on August 8, 2022)
- Form of Retention Bonus Agreement of Y-mAbs Therapeutics A/S (Filed With SEC on August 8, 2022)
- Retention Bonus Agreement, dated May 30, 2022 by and between EVP and Chief Financial Officer, Bo Kruse and Y-mAbs Therapeutics A/S (Filed With SEC on August 8, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on August 8, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (as amended, directors) (Filed With SEC on November 5, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (as amended, employees, consultants and service providers other than directors) (Filed With SEC on November 5, 2020)
